OMEICOS Therapeutics Strengthens Board of Directors with the Appointment of Christian Schetter

BERLIN & BOSTON--(BUSINESS WIRE)--OMEICOS Therapeutics, a biopharmaceutical company developing first-in-class small molecule therapeutics for the prevention and treatment of cardiovascular and ophthalmic diseases, today announced the appointment of Christian Schetter, Ph.D., as an independent Board Member. Christian has over 20 years' industry experience across the life sciences sector, and most recently joined venture capital firm Arix Bioscience plc as an Entrepreneur in Residence. Before tha

Full Story →